Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

NCT00652873 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

To Determine Bioequivalence Under Fed Conditions

Interventions

DRUG: Cabergoline
DRUG: Dostinex

Sponsor

Par Pharmaceutical, Inc.

Collaborators

[object Object]